Quitting also lowers your risk of heart and lung problems such as chronic obstructive pulmonary disease (COPD), lung infections, and circulation around your heart and other body parts. People who quit ...

Conclusion. Results of the single dose azithromycin trials reviewed here demonstrate that this regimen is safe and effective and results in excellent compliance in children with uncomplicated AOM.

Patients were randomized to receive azithromycin oral suspension either as a single 30-mg/kg dose followed by three doses of placebo, or 10 mg/kg once daily for 3 days plus one dose of placebo or ...

Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...

COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution.

According to the results of a study involving pathogen monitoring for nosocomial infections, Ureaplasma urealyticum, Escherichia coli, Enterococcus and Streptococcus are the most common infectious ...

Many people with chronic lung diseases such as COPD or asthma use a nebulizer to take their medication in the form of a mist that is inhaled into the lungs. Nebulizers are often recommended for ...

Among patients who have never smoked—“never-smokers”—those with lung cancer (LC) are more likely to have been diagnosed with an inflammatory disease, according to a study published in Nature ...

余庆县关于拒绝“升学宴”“谢师宴”的倡议书全县干部、教师、考生、家长及社会各界朋友们：蝉鸣送夏，又逢金榜题名时。值此升学之际，为 ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.

In azithromycin-treated clusters, macrolide resistance rose from 21.7% at baseline to 31.9% at 6 months, and remained high at 32.1% at 3.5 years. Resistance also increased in placebo-treated clusters, ...

COPD — chronic obstructive pulmonary disease — “is a tough disease,” says Colleen Brennan-Martinez, 64, a retired nurse practitioner from New York City whose father, James Brennan, died from COPD in ...